about
Individualized survival and treatment response predictions in breast cancer patients: involvements of phospho-EGFR and phospho-Her2/neu proteinsIncreased copy number at 3p14 in breast cancerIn vivo fiber-based multicolor photoacoustic detection and photothermal purging of metastasis in sentinel lymph nodes targeted by nanoparticles.Integrative genomic data mining for discovery of potential blood-borne biomarkers for early diagnosis of cancer.A novel model for Ki67 assessment in breast cancer.Differences in integrin expression and signaling within human breast cancer cells.Biomarker signatures of mitochondrial NDUFS3 in invasive breast carcinoma.Critical roles of DMP1 in human epidermal growth factor receptor 2/neu-Arf-p53 signaling and breast cancer development.Dmp1α inhibits HER2/neu-induced mammary tumorigenesis.gef gene expression in MCF-7 breast cancer cells is associated with a better prognosis and induction of apoptosis by p53-mediated signaling pathwayBreast cancer biomarkers and molecular medicine: part II.Letrozole in the neoadjuvant setting: the P024 trial.Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.Validation of a new classifier for the automated analysis of the human epidermal growth factor receptor 2 (HER2) gene amplification in breast cancer specimens.Different Expression of Extracellular Signal-Regulated Kinases (ERK) 1/2 and Phospho-Erk Proteins in MBA-MB-231 and MCF-7 Cells after Chemotherapy with Doxorubicin or DocetaxelDNA methylation in breast and colorectal cancers.Potential biomarkers in the sera of breast cancer patients from bahawalpur, pakistan.MammaPrint 70-gene signature: another milestone in personalized medical care for breast cancer patients.Identification of potential serum biomarkers for breast cancer using a functional proteomics technologySerum atrial natriuretic peptide: a suspected biomarker of breast cancerStress-induced EGF receptor signaling through STAT3 and tumor progression in triple-negative breast cancer.Identification of novel breast cancer-associated transcripts by UniGene database mining and gene expression analysis in normal and malignant cells.Identification of proteins binding to E-Box/Ku86 sites and function of the tumor suppressor SAFB1 in transcriptional regulation of the human xanthine oxidoreductase gene.The prognostic value of apoptotic and proliferative markers in breast cancer.Overexpression of ANLN contributed to poor prognosis of anthracycline-based chemotherapy in breast cancer patients.
P2860
Q23916643-257B8F86-F124-4C08-A9B9-9ABA5E6564FBQ24530212-E0E0DE9C-F5AA-4D61-BB70-7FDB14961F46Q30454388-DB18AD29-BE27-46C9-AEEB-E93964BE08E2Q33382997-5B530D6E-0341-41D5-A835-EF531833AE61Q33801255-1FAD5ED4-41E7-4C49-8B8C-FF5BDDE060A1Q33959863-AE7BF007-A396-4058-8D23-D67D7BB4CF49Q34210845-8F0864F5-90AE-4885-806A-A2337688F3B4Q34778229-C99681E9-7146-47C1-9B35-06C181720DF9Q35035710-38ECB1C6-9F9B-49EF-B4BE-CC7591FB1887Q35600102-2D6BD3AA-BC4F-4C99-AD21-11D3530D4924Q35680309-7026A059-B019-4CDA-8AC7-9842FABC6CF8Q36026549-A8B1A002-9B26-4257-8708-37E6D83E38C0Q36147459-DF6CB92E-6726-449E-92CF-4776875BFB36Q36646136-373AE330-E29E-4F3D-AD29-64AD364ECC2AQ36652542-F012A6BA-3999-4C0E-9215-1A61A60AD002Q36803766-5135CC5C-3D5E-43FC-BAFD-64899BC4B8C2Q37218912-92335422-BA1B-4636-AA85-6853D0046D47Q37542251-FDEC8D37-8F32-4F90-8321-3C065B82816EQ37697844-AE245A00-2199-4CCA-978A-DCB974D715A7Q37743146-3775B8BD-B4F2-4945-B70C-AD4B53F8D953Q39088864-94C64A45-C428-47D0-B54A-F1F3EE542602Q39229575-4EB29BD5-0942-4B61-A237-2876E850E5E1Q42275228-2BD2B053-AFDC-4A08-B9B7-02997087AA86Q46033699-799AB6BB-D711-4211-BBE3-9FE80606F50CQ51119330-5071FCBF-6A17-441E-9E5A-3D6FACCE718C
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Breast cancer biomarkers and molecular medicine.
@ast
Breast cancer biomarkers and molecular medicine.
@en
type
label
Breast cancer biomarkers and molecular medicine.
@ast
Breast cancer biomarkers and molecular medicine.
@en
prefLabel
Breast cancer biomarkers and molecular medicine.
@ast
Breast cancer biomarkers and molecular medicine.
@en
P2093
P2860
P356
P1476
Breast cancer biomarkers and molecular medicine.
@en
P2093
Edwin Clark
Gabriel N Hortobagyi
Gerald P Linette
James Stec
Jeffrey S Ross
Lajos Pusztai
Mark Ayers
Nick Leschly
W Fraser Symmans
P2860
P304
P356
10.1586/14737159.3.5.573
P577
2003-09-01T00:00:00Z